Rivaroxaban is the only FDA-approved anticoagulant used in patients with peripheral artery disease and coronary artery disease.
Tigris Haran, PharmD
Advertisement
Articles by Tigris Haran, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
A Healthy Gut Could Improve Mental Health
2
FDA Approves First Oral GLP-1 for Weight Management
3
Reimagining Pharmacy: A Call to Action for Pharmacy Professionals
4
FDA Approves Milestone Oral Therapy for Adults With Thalassemia Anemia
5